Covid-19 Research

Article Figures

Detoxification and Characterization of an Alpha Nanotoxoid of Clostridium septicum In vitro and In vivo

View article figures, article metadata, topics, DOI, abstract, and related articles from the JBRES article record.

View Abstract Article Library
Article Type: Research Article Published: 2025-12-30 Volume/Issue: 6 / 12 Pages: 2017-2031

Detoxification and Characterization of an Alpha Nanotoxoid of Clostridium septicum In vitro and In vivo

Emami T, Alimolaei M, Pardis R, Abbasi E, Khiav LA and Golchinfar F
Abstract FullText HTML PDF DOI
Vaccines Microbiology Biology
Detoxification and Characterization of an Alpha Nanotoxoid of Clostridium septicum In vitro and In vivo
jbres2247-g001-20260602093229-b4fe89ba.webp

Article Figures

Abstract

<p>One solution to eliminate toxins is to trap them in polymer nanoparticles. Alpha clostridial toxins typically form pores in the cell membrane, allowing them to enter cells and exert their destructive and deadly effects. However, using red blood cells whose membranes are coated with clostridial nanoparticles and toxins can neutralize the virulence of the toxin more efficiently through the spontaneous trapping of toxin nanoparticles in these membranes. <br>In this research, Clostridium septicum was cultured, and its alpha toxin was semi-purified using chromatography and ultrafiltration. The alpha toxin was encapsulated in PLGA polymer nanoparticles, and red blood cells were prepared from mice and turned into red blood cell silhouettes. The polymer nanoparticles were then enclosed in the red blood cell silhouettes using an extruder, and the size of the resulting nanoparticles was evaluated using electron microscopy. This study demonstrates successful encapsulation, detoxification, and uptake by macrophages, but immunogenicity remains to be evaluated in dedicated vaccination studies. The formulated nanotoxoid showed reduced local toxicity and evidence of biocompatibility in mice, supporting its potential as a candidate for future vaccine development. The manuscript now describes the platform as and application of an established nanotoxoid strategy to a distinct toxin, rather than presenting it as a new concept in nanotechnology.<br></p>

Similar Topic Articles

  • Advances in Personalized Medicine Personalized Neoantigen Vaccines and Immune Checkpoint Inhibitor Combination Treatments
    Priya Hays*
    Published: 2025-02-28
    Abstract FullText HTML PDF DOI
  • The Recombinant NS3 Protein a Potential Antigen for Dengue Vaccine Development
    Rosa Ramirez Bartutis*
    Published: 2024-04-05
    Abstract FullText HTML PDF DOI
  • A Presentation of Analyses of COVID-19 Vaccine Samples, Blood Samples, Urine Samples, Foot Bath Samples, Sitz Bath Samples, and Skin-Extract Samples
    Ki-Yeob Jeon*, Sunyoung Park, Daniel Broudy and Hyung-Don Joo
    Published: 2023-02-09
    Abstract FullText HTML PDF DOI
  • Do COVID-19 RNA-Injections Affect Male Fertility? Latest Facts and Perspective
    Werner Bergholz and Klaus Steger*
    Published: 2023-01-24
    Abstract FullText HTML PDF DOI
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership